Considering the growing aging population prone to conditions associated with muscle wasting and insulin resistance, such as sarcopenia, cancer, obesity, and diabetes, investigating the effect of ActRIIA/IIB blockade on muscle mass and strength, insulin-mediated glucose uptake, and glycemic control is crucial. Here, INS is linked to Insulin resistance.